Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats

Biological Psychiatry

Volumn 57, Issue 4, 2005, Pages 343-350

  Carlezon Jr , William A ^a   Mague, Stephen D ^a   Parow, Aimee M ^a   Stoll, Andrew L ^a   Cohen, Bruce M ^a   Renshaw, Perry F ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Depression; Energy; Membrane; Model; Phospholipids; Rat

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; OMEGA 3 FATTY ACID; URIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG POTENTIATION; FORCED SWIMMING TEST; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 13444254125     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2004.11.038     Document Type: Article

References (57)

1. P.B. Adams, S. Lawson, A. Sanigorski, A.J. Sinclair Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression Lipids 31 1996 S157 161
2. S.M. Babb, L.L. Wald, B.M. Cohen, R.A. Villafuerte, S.A. Gruber, D.A. Yurgelun-Todd, P.F. Renshaw Chronic citicoline increases phosphodiesters in the brains of healthy older subjects an in vivo phosphorus magnetic resonance spectroscopy study Psychopharmacology 161 2002 248 254
3. F. Borsini, A. Meli Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacol 94 1988 147 160
4. J.L. Buttriss, A.T. Diplock The relationship between alpha-tocopherol and phospholipid fatty acids in rat liver subcellular membrane fractions Biochem Biophys Acta 962 1988 81 90
5. W.A. Carlezon Jr, A.M. Pliakas, A.M. Parrow, M.J. Detke, B.M. Cohen, P.F. Renshaw Antidepressant-like effects of cytidine in the forced swim test in rats Biol Psychiatry 51 2002 882 889
6. I.J. Cartwright, A.G. Pockley, J.H. Galloway, M. Greaves, F.E. Preston The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers Atherosclerosis 55 1985 267 281
7. W.M. Clark, B.J. Williams, K.A. Selzer, R.M. Zweifler, L.A. Sabounjian, R.E. Gammans A randomized efficacy trial of citicoline in patients with acute ischemic stroke Stroke 30 1999 2592 2597
8. J.T. Coyle, R.S. Duman Finding the intracellular signaling pathways affected by mood disorder treatments Neuron 38 2003 157 160
9. S.R. Dager, S.D. Friedman, A. Parow, C. Demopulos, A.L. Stoll, I.K. Lyoo Brain metabolic alterations in medication-free patients with bipolar disorder Arch Gen Psychiatry 61 2004 450 458
10. M.J. Detke, M. Rickels, I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacol 121 1995 66 72
11. R.S. Duman Depression a case of neuronal life and death? Biol Psychiatry 56 2004 140 145
12. R.S. Duman, G.R. Heninger, E.J. Nestler A molecular and cellular theory of depression Arch Gen Psychiatry 54 1997 597-60
13. R. Edwards, M. Peet, J. Shay, D. Horrobin Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients J Affect Disord 48 1998 149 155
14. G. Ende, D.F. Braus, S. Walter, W. Weber-Fahr, F.A. Henn The hippocampus in patients treated with electroconvulsive therapy a proton magnetic resonance spectroscopic imaging study Arch Gen Psychiatry 57 2000 937 943
15. J.H. Exton Cell signalling through guanine-nucleotide-binding regulatory proteins (G proteins) and phospholipases Eur J Biochem 243 1997 10 20
16. M.P. Freeman Omega-3 fatty acids in psychiatry a review Ann Clin Psychiatry 12 2000 159 165
17. D.S. Heron, M. Shinitzky, M. Hershkowitz, D. Samuel Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes Proc Natl Acad Sci USA 77 1980 7463 7467
18. J.R. Hibbeln Fish consumption and major depression Lancet 351 1998 1213
19. J.R. Hibbeln, M. Linnoila, J.C. Umhau, R. Rawlings, D.T. George, N. Salem Jr Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics Biol Psychiatry 44 1998 235 242
20. F. Hirashima, A.M. Parow, A.L. Stoll, C.M. Demopulos, K.E. Damico, M.L. Rohan Omega-3 fatty acid treatment decreases T2 whole brain relaxation times in bipolar disorder Am J Psychiatry 161 2004 1922 1924
21. T. Kato, N. Kato Mitochondrial dysfunction in bipolar disorder Bipolar Disord 2 2000 180 190
22. C. Konradi, M. Eaton, M.L. MacDonald, J. Walsh, F.M. Benes, S. Heckers Molecular evidence for mitochondrial dysfunction in bipolar disorder Arch Gen Psychiatry 61 2004 300 308
23. S. Knapp, R.J. Wurtman Enhancement of free fatty acid incorporation into phospholipids by choline plus cytidine Brain Res 822 1999 52 55
24. W.E. Lands Biochemistry and physiology of ω-3 fatty acids FASEB J 6 1992 2530 2536
25. A.M. Llorente, C.L. Jensen, R.G. Voigt, J.K. Fraley, M.C. Berretta, W.C. Heird Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing Am J Obstet Gynecol 188 2003 1348 1353
26. C.A. Locke, A.L. Stoll Omega-3 fatty acids in major depression World Rev Nutr Diet 89 2001 173 185
27. I. Lopez-Coviella, J. Agut, V. Savci, J.A. Ortiz, R.J. Wurtman Evidence that 5'-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels J Neurochem 65 1995 889 894
28. M. Maes, A. Christophe, J. Delanghe, C. Altamura, H. Neels, H.Y. Meltzer Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients Psychiatry Res 85 1999 275 291
29. L.B. Marangell, J.M. Martinez, H.A. Zboyan, H. Chong, L.J. Puryear Omega-3 fatty acids for the prevention of postpartum depression negative data from a preliminary, open-label pilot study Depress Anxiety 19 2004 20 23
30. L.B. Marangell, J.M. Martinez, H.A. Zboyan, B. Kertz, H.F. Kim, L.J. Puryear A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression Am J Psychiatry 160 2003 996 998
31. M. Martinet, P. Fonlupt, H. Pacheco Effects of cytidine-5'- diphosphocholine on norepinephrine, dopamine and serotonin synthesis in various regions of the rat brain Arch Int Pharmacodyn 239 1979 52 56
32. C.M. Moore, J.L. Breeze, S.A. Gruber, S.M. Babb, B.B. Frederick, R.A. Villafuerte Choline, myo-inositol and mood in bipolar disorder a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex Bipolar Disord 3 2000 207 216
33. C.M. Moore, J.D. Christensen, B. Lafer, M. Fava, P.F. Renshaw Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects a phosphorous-31 magnetic resonance spectroscopy study Am J Psychiatry 154 1997 116 118
34. B. Nemets, Z. Stahl, R.H. Belmaker Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder Am J Psychiatry 159 2002 477 479
35. E.J. Nestler Antidepressant treatments in the 21st century Biol Psychiatry 44 1998 526 533
36. E.J. Nestler, E. Gould, H. Manji, M. Buncan, R.S. Duman, H.K. Greshenfeld Preclinical models status of basic research in depression Biol Psychiatry 52 2002 503 528
37. T. Nomura, T. Nishizaki, T. Enomoto, H. Itoh A long-lasting facilitation of hippocampal neurotransmission via a phospholipase A2 signaling pathway Life Sci 68 2001 2885 2891
38. M.A. Pacheco, R.S. Jope Phosphoinositide signaling in human brain Prog Neurobiol 50 1996 255 273
39. M. Peet, D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Arch Gen Psychiatry 59 2002 913 919
40. M. Peet, B. Murphy, J. Shay, D. Horrobin Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients Biol Psychiatry 43 1998 315 319
41. A.M. Pliakas, R. Carlson, R.L. Neve, C. Konradi, E.J. Nestler, W.A. Carlezon Jr Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element binding protein expression in nucleus accumbens J Neurosci 21 2001 7397 7403
42. C. Popp-Snijders, J.A. Schouten, A.P. de Jong, E.A. van der Veen Effect of dietary cod-liver oil on the lipid composition of human erythrocyte membranes Scand J Clin Lab Invest 44 1984 39 46
43. R.D. Porsolt, M. Le Pichon, M. Jalfre Depression a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
44. D. Raederstorff, C.A. Meier, U. Moser, P. Walter Hypothyroidism and thyroxin substitution affect the n-3 fatty acid composition of rat liver mitochondria Lipids 26 1991 781 787
45. P.F. Renshaw, S. Daniels, L.H. Lundahl, V. Rogers, S.E. Lukas Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects a preliminary report Psychopharmacol 142 1999 132-13
46. U.I. Richardson, C.J. Watkins, C. Pierre, I.H. Ulus, R.J. Wurtman Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells Brain Res 971 2003 161 167
47. J.J. Secades, G. Frontera CDP-choline pharmacological and clinical review Methods Find Clinical Pharmacol 17 Suppl B 1995 1 54
48. A. Shaldubina, B. Nemets, Y. Bersudsky Lack of effect of eicosapentaenoic acid in the Porsolt forced swimming test model of depression Acta Neuropsychiatrica 14 2002 203 206
49. H.U. Shetty, Q.R. Smith, K. Washizaki, S.I. Rapoport, A.D. Purdon Identification of two molecular species of rat brain phosphatidylcholine that rapidly incorporate and turn over arachidonic acid in vivo J Neurochem 67 1996 1702 1710
50. S.B. Sonawalla, P.F. Renshaw, C.M. Moore, J.E. Alpert, A.A. Nierenberg, J.F. Rosenbaum, M. Fava Compounds containing cytosolic choline in the basal ganglia a potential biological marker of true drug response to fluoxetine Am J Psychiatry 156 1999 1638 1640
51. R.J. Steingard, D.A. Yurgelun-Todd, J. Hennen, J.C. Moore, C.M. Moore, K. Vakili Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy Biol Psychiatry 48 2000 1053 1061
52. A.L. Stoll, W.E. Severus, M.P. Freeman, S. Rueter, H.A. Zboyan, E. Diamond Omega 3 fatty acids in bipolar disorder a preliminary double-blind, placebo-controlled trial Arch Gen Psychiatry 56 1999 407 412
53. K.P. Su, S.Y. Huang, C.C. Chiu, W.W. Shen Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13 2003 267 271
54. A. Tanskanen, J.R. Hibbeln, J. Hintikka, K. Haatainen, K. Honkalampi, H. Viinamaki Fish consumption, depression, and suicidality in a general population Arch Gen Psychiatry 58 2001 512 513
55. A. Tanskanen, J.R. Hibbeln, J. Tuomilehto, A. Uutela, A. Haukkala, H. Viinamaki Fish consumption and depressive symptoms in the general population in Finland Psychiatr Serv 52 2001 529 531
56. P. Willner The validity of animal models of depression Psychopharmacol 83 1984 1 16
57. R.J. Wurtman, M. Regan, I. Ulus, L. Yu Effect of oral CDP-choline on plasma choline and uridine levels in humans Biochem Pharmacol 60 2000 989 992